This is a single speech (committee meeting) resource from the openparliament.ca API. If you’re new here, you might want to look at the documentation. If API and JSON are gibberish to you, you’re better off at our main site.

Content

Get this resource as raw JSON.

See the corresponding webpage.

{
    "time": "2021-02-18 12:20:00",
    "attribution": {
        "en": "Mr. Mark Lievonen",
        "fr": "M. Mark Lievonen"
    },
    "content": {
        "en": "<p data-HoCid=\"6516498\" data-originallang=\"en\">If you take a step back in time to June, July and August when we were getting going, it's a bit of a mind-boggling task that we were given to recommend....</p>\n<p data-HoCid=\"6516499\" data-originallang=\"en\"> Our mandate was to provide advice to secure safe and efficacious vaccines for Canadians as soon as possible.</p>\n<p data-HoCid=\"6516500\" data-originallang=\"en\">At that time, there were no vaccines licensed or developed; they were under way for being developed. There were international candidates and domestic candidates and we had to assess, review and meet with companies and come up with recommendations about what vaccines might be available in the future. When we provided advice to the government, the seven candidate vaccines that we recommended across three platforms weren't even approved yet. There was a risk in buying, securing and entering into agreements for products that weren't even licensed yet.</p>\n<p data-HoCid=\"6516501\" data-originallang=\"en\">The government took our advice; they reacted to it and moved to quickly secure advance purchase agreements.</p>",
        "fr": "<p data-HoCid=\"6516498\" data-originallang=\"en\">Si vous remontez dans le temps jusqu'en juin, juillet et ao\u00fbt, au moment o\u00f9 nous amorcions notre travail, on nous avait confi\u00e9 la t\u00e2che un peu ahurissante de recommander...</p>\n<p data-HoCid=\"6516499\" data-originallang=\"en\"> Notre mandat consistait \u00e0 fournir des conseils pour garantir aux Canadiens des vaccins s\u00fbrs et efficaces dans les d\u00e9lais les plus brefs.</p>\n<p data-HoCid=\"6516500\" data-originallang=\"en\">\u00c0 l'\u00e9poque, aucun vaccin n'avait \u00e9t\u00e9 homologu\u00e9 ou mis au point; ils \u00e9taient en cours d'\u00e9laboration. Il y avait des candidats internationaux et des candidats nationaux, et nous devions examiner, rencontrer et \u00e9valuer les entreprises productrices et formuler des recommandations sur les vaccins qui pourraient \u00eatre offerts \u00e0 l'avenir. Lorsque nous avons conseill\u00e9 le gouvernement, les sept vaccins candidats reposant sur trois plateformes que nous avions recommand\u00e9s n'avaient m\u00eame pas encore \u00e9t\u00e9 approuv\u00e9s. Il \u00e9tait risqu\u00e9 d'acheter des produits qui n'avaient m\u00eame pas encore \u00e9t\u00e9 homologu\u00e9s ou de conclure des ententes d'approvisionnement pour les obtenir.</p>\n<p data-HoCid=\"6516501\" data-originallang=\"en\">Le gouvernement a suivi nos conseils; il a r\u00e9agi, et il a pris des mesures pour conclure rapidement des accords d'achat anticip\u00e9s.</p>"
    },
    "url": "/committees/industry/43-2/18/mark-lievonen-16/",
    "politician_url": null,
    "politician_membership_url": null,
    "procedural": false,
    "source_id": "11136935",
    "document_url": "/committees/industry/43-2/18/",
    "related": {
        "document_speeches_url": "/speeches/?document=%2Fcommittees%2Findustry%2F43-2%2F18%2F"
    }
}